Teva Pharmaceutical Industries TEVA
$39.23 +$0.69 (+1.79%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.23 0.00%
Open$38.46
Prev close$38.54
Day range$38.30 – $39.91
Volume6.81M
Market cap$45.77B
P/E (TTM)91.2
Dividend yield–
Analyst view
ConsensusBuy
Analysts13
Average target$51.54+31.4% vs. price
- Buy 100%
Low $45.94Now $39.23Avg $51.54High $57.00
Recent rating changes
The last 20 actions on file set price targets from $44.00 to $57.00, averaging $50.72.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 19 Nov 2026 | Leerink Partners | BUY | – |
| 18 Nov 2026 | Barclays | BUY | $50.00 |
| 17 Nov 2026 | H.C. Wainwright | BUY | $54.00 |
| 16 Nov 2026 | Argus Research | BUY | $50.00 |
| 12 Nov 2026 | TD Cowen | BUY | $57.00 |
| 12 Nov 2026 | Piper Sandler | BUY | $56.00 |
| 12 Nov 2026 | Evercore | BUY | – |
| 12 Nov 2026 | H.C. Wainwright | BUY | $54.00 |
| 12 Nov 2026 | Oppenheimer | BUY | $54.00 |
| 11 Nov 2026 | BofA Securities | BUY | $48.00 |
| 4 Nov 2026 | Scotiabank | BUY | $47.00 |
| 4 Nov 2026 | Goldman Sachs | BUY | $55.00 |
| 4 Nov 2026 | H.C. Wainwright | BUY | $54.00 |
| 4 Nov 2026 | J.P. Morgan | BUY | $50.00 |
| 3 Nov 2026 | BofA Securities | BUY | $48.00 |
| 3 Nov 2026 | Scotiabank | BUY | $47.00 |
| 2 Nov 2026 | H.C. Wainwright | BUY | $52.00 |
| 23 Oct 2026 | Piper Sandler | BUY | $44.00 |
| 15 Oct 2026 | Barclays | BUY | $47.00 |
| 12 Oct 2026 | Leader Capital Markets | BUY | $45.94 |
No comments yet — be the first to weigh in on TEVA.
Sign in to join the discussion.